XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A Profit Margin

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A (XOMAP) currently reports a profit margin of 64.89% as of March 2026. That compares with -7.82% in the prior-year period — up 929.3% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's profit margin history and peer comparisons.

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's profit margin increased from -7.82% to 64.89% — a 929.3% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's profit margin of 64.89% is higher than the Healthcare sector average of 13.89%. That is roughly 367.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A's current 64.89% should be judged against Healthcare norms (sector average: 13.89%) and against XOMAP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 64.89%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for XOMA Royalty - 8.625% PRF PERPETUAL USD 25 - Ser A, and consider following XOMAP for alerts when major investors trade the stock.